Discover 1,707 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,707
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Farmington Hills MI, Atlanta GA, Farmington NM, Reno NV,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07541170
Phase3, Recruiting
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Location: Farmington Hills MI, York PA, Roanoke VA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 45 - 70+
Code: NCT07613294
Phase3, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Detroit MI, Grand Rapids MI, Columbus OH, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Detroit MI, Grand Rapids MI, Hamilton, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase3, Recruiting
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
for
Clear Cell Renal Cell Carcinoma, Solid Tumors
Location: Detroit MI, Cleveland OH, Pittsburgh PA, Louisville KY,
Sponsor: Arcus Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05536141
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Detroit MI, Ann Arbor MI, Chicago IL, Milwaukee WI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase1, Phase2, Recruiting
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
for
Metastatic Non-small Cell Lung Cancer
Location: Detroit MI, Maumee OH, Brampton, Toronto, Pittsburgh PA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06417814
Phase3, Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Detroit MI, Hamilton, Brampton, Toronto, Chicago IL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase3, Recruiting
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
for
Sepsis, Acute Kidney Injury
Location: Detroit MI, Philadelphia PA, Winston-Salem NC,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07215702
Phase2, Recruiting
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Detroit MI, Grand Rapids MI, Brampton, Toronto, Barrie,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06921785
Phase3, Recruiting
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
for
Delayed Graft Function, DGF, Kidney Transplant
Location: Detroit MI, Ann Arbor MI, Toronto, Chicago IL,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06830798
Phase3, Recruiting
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
for
Acute Coronary Syndrome
Location: Detroit MI, Mount Clemens MI, Dearborn MI, Ypsilanti MI,
Sponsor: DalCor Pharmaceuticals
Sex: All
Age: 45+
Code: NCT05918861
Phase3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Detroit MI, Garden City MI, Ann Arbor MI, Sarnia,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase3, Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity